NeoCore Technology Co., Ltd. (TPEX:4131)

Market Cap	1.54B +18.3%
Revenue (ttm)	190.10M +178.4%
Net Income	-20.46M
EPS	-0.52
Shares Out	39.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,623
Average Volume	81,547
Open	38.75
Previous Close	38.90
Day's Range	38.50 - 39.60
52-Week Range	28.80 - 45.80
Beta	-0.33
RSI	47.19
Earnings Date	Mar 13, 2026

About NeoCore Technology

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company’s products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and cha...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1987
• Employees: 44
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4131

Financial Performance

In 2024, NeoCore Technology's revenue was 61.55 million, a decrease of -4.92% compared to the previous year's 64.73 million. Losses were -48.14 million, -25.54% less than in 2023.